RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 1 filers reported holding RELMADA THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $196 | -40.1% | 65,275 | -50.8% | 0.00% | – |
Q2 2023 | $327 | -53.8% | 132,772 | -57.6% | 0.00% | -100.0% |
Q1 2023 | $708 | -6.8% | 313,175 | +43.8% | 0.00% | 0.0% |
Q4 2022 | $760 | -99.8% | 217,810 | +1412.6% | 0.00% | – |
Q4 2021 | $324,000 | -20.2% | 14,400 | -7.1% | 0.00% | -100.0% |
Q3 2021 | $406,000 | – | 15,500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
VR Adviser, LLC | 668,440 | $25,147,000 | 4.92% |
TANG CAPITAL MANAGEMENT LLC | 500,000 | $18,810,000 | 3.40% |
ACUTA CAPITAL PARTNERS, LLC | 277,000 | $10,421,000 | 2.83% |
PARSONS CAPITAL MANAGEMENT INC/RI | 455,137 | $17,122,000 | 1.67% |
RTW INVESTMENTS, LP | 1,511,337 | $56,857,000 | 1.37% |
Avoro Capital Advisors LLC | 1,500,000 | $56,430,000 | 0.80% |
Pegasus Asset Management, Inc. | 26,958 | $1,014,000 | 0.64% |
RA Capital Management | 781,290 | $29,392,000 | 0.54% |
TIEDEMANN ADVISORS, LLC | 269,839 | $10,151,000 | 0.49% |
Boxer Capital, LLC | 300,000 | $11,286,000 | 0.39% |